Gaoming Hou

Gaoming Hou

Auto-generated profile, based on publicly available information

Gaoming Hou

Department of Urology, Second Affiliated Hospital of Shantou University Medical College, Shantou, China

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2026 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
QYQinglong Yang
Qinglong Yang
HCHaolin Chen
Haolin Chen
NLNan Luo
Nan Luo
HLHanyuan Lin
Hanyuan Lin
HTHaoxian Tang
Haoxian Tang
QYQingtao Yang
Qingtao Yang
Benign prostatic hyperplasia (BPH) frequently affects men in middle and later life; however, the potential influence of ultra-processed food (UPF) consumpt

1 January 2026 in The World Journal of Men's Health
Verified
Journal Article
Open access
QYQinglong Yang
Qinglong Yang
HCHaolin Chen
Haolin Chen
ZLZexuan Liu
Zexuan Liu
GHGaoming Hou
Gaoming Hou
WLWenqiang Liao
Wenqiang Liao
QYQingtao Yang
Qingtao Yang
Benign prostatic hyperplasia (BPH) and rheumatoid arthritis (RA) have both been associated with inflammatory processes; however, their association remains unclear. This study explored the prospective association between BPH and the subsequent risk of RA using data from the UK Biobank, and further evaluated whether the systemic immune-inflammation index (SII) and the neutrophil-to-lymphocyte ratio (NLR) are associated with this relationship. A total of 222,891 males without RA or prostate cancer at baseline were included. BPH was identified through self-report, hospital ICD-10 codes (N40), and primary care records. Incident RA was defined using hospital ICD-10 codes (M05 to M06). Multivariable Cox proportional hazards models were applied to assess the association between BPH and risk of incident RA. Mediation analyses were used to explore the potential role of SII and NLR in this association. Sensitivity analyses, including subgroup analyses, multiple imputation, exclusion of early RA cases, and competing risk models, were performed to test robustness. During a median follow-up of 14 years, 2,252 incident RA cases were documented. After multivariable adjustment, BPH was associated with a higher risk of RA (hazard ratio=1.19, 95% confidence interval: 1.03 to 1.37). The association remained consistent across sensitivity analyses. Mediation analyses suggested that SII and NLR may partly account for the observed association between BPH and RA (4.28% and 7.25%, respectively). BPH was associated with an increased risk of RA, and systemic inflammatory markers were also associated with this relationship.